Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
70
KYMR Quote, Financials, Valuation and Earnings
Last price:
$81.31
Seasonality move
:
-9.68%
Day range:
$81.04 - $82.86
52-week range:
$19.45 - $103.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
152.42x
P/B ratio:
6.18x
Volume:
418.6K
Avg. volume:
1.2M
1-year change:
93.53%
Market cap:
$5.9B
Revenue:
$47.1M
EPS (TTM):
-$3.60
Earnings Data
Next earnings date for KYMR
Feb 26
2026
Most recent earnings per share
-$0.94
Missed by $0.16
(Nov 4/2025)
Consensus Estimate
-$0.78
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KYMR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $14.6M | -- | -- | -$0.78 | -- |
| 11/04/2025 | Q3 | $23.6M | $2.8M | -$0.94 | -$0.78 | -$0.16 |
| 08/11/2025 | Q2 | $24.2M | $11.5M | -$0.95 | -$0.80 | -$0.15 |
| 05/08/2025 | Q1 | $10.7M | $22.1M | -$0.82 | -$0.91 | $0.09 |
| 02/27/2025 | Q4 | $14.8M | $7.4M | -$0.88 | -$0.79 | -$0.10 |
| 10/31/2024 | Q3 | $10.3M | $3.7M | -$0.82 | -$0.84 | $0.02 |
| 08/07/2024 | Q2 | $12.6M | $25.7M | -$0.58 | -$0.66 | $0.08 |
| 05/02/2024 | Q1 | $13.1M | $10.3M | -$0.69 | -$0.72 | $0.03 |
| 02/22/2024 | Q4 | $42M | $47.9M | -$0.25 | -$0.38 | $0.13 |
| 11/02/2023 | Q3 | -- | $4.7M | -$0.90 | -- | -- |
| 08/03/2023 | Q2 | -- | $16.5M | -$0.67 | -- | -- |
| 05/04/2023 | Q1 | -- | $9.5M | -$0.70 | -- | -- |
| 02/23/2023 | Q4 | -- | $16.1M | -$0.60 | -- | -- |
| 11/03/2022 | Q3 | -- | $9.6M | -$0.79 | -- | -- |
| 08/09/2022 | Q2 | -- | $11.5M | -$0.78 | -- | -- |
| 05/03/2022 | Q1 | -- | $9.6M | -$0.71 | -- | -- |
| 02/24/2022 | Q4 | -- | $15.3M | -$0.66 | -- | -- |
| 11/10/2021 | Q3 | -- | $20.3M | -$0.56 | -- | -- |
| 08/06/2021 | Q2 | -- | $18.5M | -$0.55 | -- | -- |
| 05/06/2021 | Q1 | -- | $18.7M | -$0.29 | -- | -- |
| 03/11/2021 | Q4 | -- | $12.8M | -$0.29 | -- | -- |
| 11/05/2020 | Q3 | -- | $14.5M | -$0.39 | -- | -- |
| 06/30/2020 | Q2 | -- | $3.3M | -$0.32 | -- | -- |
| 03/31/2020 | Q1 | -- | $3.4M | -$0.45 | -- | -- |
| 12/31/2019 | Q4 | -- | $1.8M | -$0.26 | -- | -- |
| 09/30/2019 | Q3 | -- | $950K | -$0.26 | -- | -- |
Kymera Therapeutics, Inc. Earnings Questions
-
How Much did Kymera Therapeutics, Inc. Generate in Revenue Last Quarter?
Kymera Therapeutics, Inc. reported $2.8M worth of top line sales in its most recent quarter.
-
Did Kymera Therapeutics, Inc. Beat Earnings Last Quarter?
Kymera Therapeutics, Inc. announced earnings per share of -$0.94 which represents a miss of analyst forecast a -$0.78 per share.
-
Is Kymera Therapeutics, Inc. Profitable?
Kymera Therapeutics, Inc. reported $615K that represents $0.01 per share over the last quarter.
-
What is the Analyst Consensus for Kymera Therapeutics, Inc. EPS Next Year?
Kymera Therapeutics, Inc.'s earnings are forecast to decrease from -$2.98 per share to -$2.84 per share next year representing a decrease of -16.04%.
-
When is Kymera Therapeutics, Inc.'s Earnings Date?
Kymera Therapeutics, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 29
Galecto, Inc. [GLTO] is down 0.73% over the past day.
Sell
20
SMX alert for Dec 29
SMX (Security Matters) Plc [SMX] is down 32.76% over the past day.
Sell
11
CDNAF alert for Dec 25
Canadian Tire Corp. Ltd. [CDNAF] is down 0% over the past day.
